11. Association of 17q with 11q allele loss and with 5-year survival in human breast cancer.
β Scribed by A.M. Thompson; B. Cohen; D. Crichton; M. Wallace; I. McKenzie; C.M. Steel
- Book ID
- 113404519
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 157 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0960-9776
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Breast-carcinoma development presumably results from multiple mutational events in tumor-associated genes. Certain results indicate that some tumor-suppressor genes may combine their pathogenetic potential to synergistically promote tumor growth. In an effort to identify such mechanisms in breast tu
An extended analysis for loss of heterozygosity (LOH) on eight chromosomes was conducted in a series of 82 Wilms tumors. Observed rates of allele loss were: 9.5% (1p), 5% (4q), 6% (6p), 3% (7p), 9.8% (11q), 28% (11p15), 13.4% (16q), 8.8% (18p), and 13.8% (22q). Known regions of frequent allele loss
We analyzed normal/tumor DNA pairs obtained from 46 patients with prostate cancers (stage B, 16 cases; C, 10 cases; D1, 4 cases; and endocrine therapy-resistant cancer-death, 16 cases) for loss of heterozygosity using 32 microsatellite markers on chromosome 18. Seventeen of the 46 cases (37%) showed